Inter-organ Communication and Pathological Interactions in Chronic Obstructive Pulmonary Disease and Inflammatory Bowel Disease: Insights into the Gut-Lung Axis - Top-Institutions - MDSpire

Inter-organ Communication and Pathological Interactions in Chronic Obstructive Pulmonary Disease and Inflammatory Bowel Disease: Insights into the Gut-Lung Axis

  • By

  • Xinying Liu

  • Shuo Yang

  • Yingying Yan

  • Lin Zhang

  • Xiaokun Yang

  • Li Liu

  • April 22, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Pulmonology
    • Gastroenterology
    • Immunology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Pulmonology
    • Gastroenterology
    • Microbiome Research

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Pulmonology
    • Gastroenterology
    • Translational Medicine

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Pulmonology
    • Gastroenterology
    • Immunology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Pulmonology
    • Gastroenterology
    • Clinical Research

Original Source(s)

Inter-organ Communication and Pathological Interactions in Chronic Obstructive Pulmonary Disease and Inflammatory Bowel Disease: Insights into the Gut-Lung Axis

  • by Xinying Liu, Shuo Yang, Yingying Yan, Lin Zhang, Xiaokun Yang, Li Liu

  • April 22, 2026

Related Content

Atypical Meningococcemia: Diagnostic Lessons From a Fatal Case

A fatal NEJM case highlights how invasive meningococcal disease—particularly serogroup W—can present without rash, masquerade as gastrointestinal illness, and rapidly progress to shock and DIC.

ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries

Prevalence, incidence, and mortality of inflammatory bowel disease in the Netherlands: development and external validation of machine learning models